TIAM1 and colorectal carcinoma: The Kaplan–Meier analysis revealed that CRC patients with high-TIAM1 expression demonstrated poorer survival, both overall (OS) and disease free survival (DFS), compared to those with low-TIAM1 expression (P = 0.0327 and P = 0.0319 respectively, Fig. 1d).